Strategically reuse your clinical trial data: opportunities, challenges, and best practices

INCLUDES CASE STUDY ON CLINICAL DATA REUSE AT ASTRAZENECA

Clinical trials are expensive. To maximize the value of the data generated during trials, pharma companies must prioritize this data's reuse. With this whitepapter, explore the evolving and multifaceted landscape of clinical trial data reuse and learn about the critical challenges that must be addressed to do so.

To illustrate the practical application of data reuse, we present information on supporting cohort building along with a case study showcasing how AstraZeneca has developed a robust infrastructure to support the efficient reuse of clinical data assets.

Register to download the whitepaper

By offering insights into current practices, barriers, and success stories, this whitepaper aims to provide stakeholders with a comprehensive understanding of the clinical trial data reuse ecosystem, along with actionable recommendations for maximizing this data’s value.

Key highlights

Clinical data reuse best practices

Understand the best practices for ensuring data standardization, quality, and security when reusing historical clinical data.

Insight into platforms for cohort building

Learn about the application of cohort building, the various tools available to support this practice, and how to overcome related data challenges.

AstraZeneca's approach to clinical data reuse

Gain insight into how AstraZeneca leverages historical clinical data, knowledge graphs, and an intuitive user interface powered by DISQOVER to drive research efficiencies and significant time-savings.